HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print February 3, 2006

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.0805466v1 79/4/818    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, L.-b. Articles by Goleva, E. Search for Related Content PubMed PubMed Citation Articles by Li, L.-b. Articles by Goleva, E.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0805466

Received for publication August 19, 2005.
Revised September 13, 2005.
Accepted for publication December 14, 2005.

Article

Divergent expression and function of glucocorticoid receptor in human monocytes and T cells

Ling-bo Li ^*, Donald Y. M. Leung ^*@, Clifton F. Hall ^*, and Elena Goleva ^*

*Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado; and Department of Pediatrics, University of Colorado Health Sciences Center, Denver

^@ To whom correspondence should be addressed. E-mail: leungd{at}njc.org.

	Abstract

Glucocorticoid (GC) insensitivity is a significant problem in the treatment of immune-mediated diseases. The current study examined whether T cells and monocytes differed in their response to GC and the potential molecular basis for their variation in response to steroids. Functional studies revealed that dexamethasone (DEX) inhibited phorbol 12-myristate 13-acetate/ionomycin-induced tumor necrosis factor and interleukin-6 production to a significantly lesser extent in monocytes than T cells. In parallel, a significantly longer period of time was required for DEX to induce the steroid-responsive gene, mitogen-induced mitogen-activated protein kinase phosphatase-1, in human monocytes as compared with T cells. It is interesting that such differences were not observed between murine T cells and monocytes. GC receptor (GCR) is a splicing variant of the classic GCR, GCR, which functions as a dominant-negative inhibitor of GCR in humans, not mice (as mice do not express GCR mRNA as a result of a difference in the murine GCR 9b exon sequence). It was found that human monocytes had a significantly higher level of GCR than T cells. Furthermore, GCR was found in the cytoplasm and nucleus of monocytes, and GCR was localized to the nucleus of T cells. This raised the possibility that GCR in the cytoplasm could affect GCR cellular shuttling in response to DEX. Indeed, we found that DEX-induced nuclear translocation of GCR was decreased in monocytes as compared with T cells. Specific RNA silencing of GCR in human monocytes resulted in enhanced steroid-induced GCR transactivation and transrepression. Our data suggest that GCR contributes to variation in the GC responses of monocytes versus T cells.

Key Words: steroid resistance • MKP-1 • dexamethasone

This article has been cited by other articles:

				M. J. M. Schaaf, D. Champagne, I. H. C. van Laanen, D. C. W. A. van Wijk, A. H. Meijer, O. C. Meijer, H. P. Spaink, and M. K. Richardson Discovery of a Functional Glucocorticoid Receptor {beta}-Isoform in Zebrafish Endocrinology, April 1, 2008; 149(4): 1591 - 1599. [Abstract] [Full Text] [PDF]

				L.-b. Li, D. Y. M. Leung, M. J. Strand, and E. Goleva ATF2 impairs glucocorticoid receptor mediated transactivation in human CD8+ T cells Blood, September 1, 2007; 110(5): 1570 - 1577. [Abstract] [Full Text] [PDF]